NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA) announced today that its Cogenics® division, a leading provider of value-based genomic solutions to the healthcare and life sciences industries, has validated installation of the Illumina iScan System in its Morrisville, North Carolina site. Illumina is a leading developer, manufacturer, and marketer of next-generation life-science tools and integrated systems for the large-scale analysis of genetic variation and biological function. Its iScan System includes a high-resolution scanner that supports rapid, sensitive, and accurate imaging of Illumina’s BeadChip-based genetic analysis products. Cogenics is the first commercial genetic services provider to install the iScan System within Illumina’s early access program and plans to use the system to further strengthen its leading portfolio of genomic services and solutions.
